Establishment and characterization of new IgD lambda type myeloma cell lines, MOLP-2 and MOLP-3, expressing CD28, CD33 antigens and the IL-6 receptor.

Source:http://linkedlifedata.com/resource/pubmed/id/8148313

Download in:

View as

General Info

PMID
8148313